SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $24,000 | -17.2% | 2,543 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $29,000 | -68.5% | 2,543 | -53.0% | 0.00% | -66.7% |
Q3 2018 | $92,000 | +10.8% | 5,411 | -7.4% | 0.01% | +20.0% |
Q2 2018 | $83,000 | +27.7% | 5,846 | +70.3% | 0.01% | +25.0% |
Q1 2018 | $65,000 | -96.0% | 3,432 | -96.5% | 0.00% | -95.1% |
Q4 2017 | $1,626,000 | +9.3% | 99,155 | +0.1% | 0.08% | +34.4% |
Q3 2017 | $1,487,000 | – | 99,089 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |